Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21)
The summary for the Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21): Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to invite investigator-initiated applications that address basic, clinical, translational, epidemiological and/or behavioral research on vulvodynia and related symptom-based conditions. The goal of the initiative is to facilitate new research on diagnostic, prevention, and therapeutic approaches to vulvodynia, a chronic pelvic pain condition in women. An expected outcome will be to provide findings useful for development of future prevention or treatment strategies. It is anticipated that these studies will increase our understanding of the pathophysiology, biologic and behavioral risk factors, natural history, and genetics of vulvodynia. By using the R21 grant mechanism, the NIH seeks to foster the introduction of novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-190, that encourage applications under the R01 traditional research grant mechanism, and PAR-10-191 that encourage applications under the R03 Small Research Grant mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
|Federal Grant Title:||Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Income Security and Social Services|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-10-192|
|Type of Funding:||Grant|
|CFDA Descriptions:||Child Health and Human Development Extramural Research|
|Current Application Deadline:||Sep 21, 2012|
|Original Application Deadline:||Sep 21, 2012|
|Posted Date:||May 07, 2010|
|Creation Date:||May 07, 2010|
|Archive Date:||Oct 21, 2012|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Grants Info Grants Information Phone 301-435-0714
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional)
- • Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
- • Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional)
- • Womens Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial ...
- • Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...